EU regulator backs use of Novo's Wegovy for obesity-related heart condition

EU regulator backs use of Novo's Wegovy for obesity-related heart condition

Submitted by admin on September 19, 2024 - 9:16pm
Source: 
Reuters
News Tags: 
Novo Nordisk
Wegovy
obesity
EMA
Europe
heart failure with preserved ejection fraction
Headline: 
EU regulator backs use of Novo's Wegovy for obesity-related heart condition
snippet: 

The European Medicines Agency backed the use of Novo Nordisk's (NOVOb.CO), opens new tab popular drug Wegovy to help ease heart failure in people with obesity, the Danish drugmaker said on Thursday.

Do Not Allow Advertisers to Use My Personal information